| Rani Therapeutics to Participate in September Investor Conferences | 09/03 16:05 | globenewswire.com |
| Rani Therapeutics Reports Second Quarter 2024 Financial Results; Provides Corporate Update | 08/06 16:05 | globenewswire.com |
| Rani Therapeutics to Participate in August Investor Conferences | 07/29 16:05 | globenewswire.com |
| Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering | 07/22 08:30 | globenewswire.com |
| Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment | 06/24 07:00 | globenewswire.com |
| Rani Therapeutics to Participate in May Investor Conferences | 05/14 08:00 | globenewswire.com |
| Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill® Capsule at Digestive Disease Week 2024 | 05/09 08:00 | globenewswire.com |
| Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update | 05/06 16:05 | globenewswire.com |
| Rani Therapeutics Holdings, Inc. (RANI) Q4 2023 Earnings Call Transcript | 03/20 19:05 | seekingalpha.com |
| Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update | 03/20 16:05 | globenewswire.com |